Asuragen

About:

Asuragen is a fully integrated diagnostics company developing mRNA-based solutions for molecular oncology and early detection of cancer.

Website: http://www.asuragen.com

Twitter/X: Asuragen

Top Investors: Merck Global Health Innovation Fund, Telegraph Hill Partners, PTV Healthcare Capital, Growth Capital Fund

Description:

Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.